Drug Eluting Balloons Catheters Market Projected at $2.61 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Drug Eluting Balloons Catheters Market Size Changed, over the years?
The market size for drug eluting balloons catheters has experienced swift growth recently. It is projected to inflate from $1.43 billion in 2024 to $1.66 billion in 2025, with a compound annual growth rate (CAGR) of 16.0%. Factors contributing to the past expansion include the rise in respiratory disorders, benefits compared to conventional inhalers, patient inclination towards dpis, government interventions for respiratory health, strategic collaborations and partnerships, advancements in drug composition, and a growing elderly population.
How Much Will the Drug Eluting Balloons Catheters Market Be Worth in 2029?
In the coming years, the market size for drug eluting balloons catheters is predicted to experience a swift expansion, reaching $2.61 billion in 2029 with an annual compound growth rate of 12.0%. This anticipated growth in the forecast period can be credited to ongoing increases in respiratory disorders, the broadening geriatric population, heightened awareness and education, emerging economies expanding their market, tailored drug formulations, regulatory backing and adherence, as well as packaging and design innovations. The forecast period also expects to see significant trends like smart inhalers with connectivity, a shift towards breath-based inhalers, focus on the needs of pediatric and geriatric patients, biologics delivery, and eco-friendly inhaler designs.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp
Which is the Largest Company in the Drug Eluting Balloons Catheters Market?
Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB
What Are the Main Market Drivers in the Drug Eluting Balloons Catheters Industry?
The drug-eluting balloon catheter market’s growth is anticipated to be fueled by the escalating prevalence of peripheral and cardiovascular diseases. Peripheral artery disease (PAD) primarily involves the narrowing of arteries that diminishes blood flow, particularly to the arms or legs, whereas cardiovascular diseases (CVDs) affect the heart and blood vessels. Drug-eluting balloon catheters, which utilize a semi-compliant angioplasty balloon enriched with an anti-proliferative agent, serve as a therapeutic strategy in battling coronary artery disease (CAD). They can act to prevent the recurrence of vascular narrowing once inside the vessel. For instance, in 2022, heart disease was responsible for approximately one-fifth of all deaths, claiming 702,880 lives, as reported by the Centers for Disease Control and Prevention in May 2024. In the United States, each year sees around 805,000 heart attacks, with 605,000 being first-time occurrences and 200,000 involving individuals with a previous history. As such, the drug-eluting balloon catheter market is boosted by the rising occurrences of peripheral and cardiovascular diseases.
Drug Eluting Balloons Catheters Market Driver: Surging demand For Minimally Invasive Techniques Boosts Drug-Eluting Balloon Catheter Market Expansion
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13429&type=smp
How Is the Drug Eluting Balloons Catheters Market Segments Structured?
The drug eluting balloons catheters market covered in this report is segmented –
1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2) By Drug: Paclitaxel, Sirolimus, Other Drugs
3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories
Subsegments:
1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters, Plain Balloon Catheters
2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Angioplasty Balloon Catheters
3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
What Strategic Trends Are Transforming the Drug Eluting Balloons Catheters Market?
Leading businesses in the drug-eluting balloon catheter market are putting more emphasis on crafting the latest generation of products utilizing cutting-edge technologies. They aim to acquire a competitive advantage in the market. For instance, in March 2024, Boston Scientific Corporation, a multinational manufacturer of medical appliances from the US and also a biomedical/biotechnology engineering enterprise, announced that it had earned approval from the U.S. Food and Drug Administration for its AGENT Drug-Coated Balloon (DCB). This innovative AGENT DCB is the inaugural drug-coated coronary balloon accessible in the U.S. for in-stent restenosis (ISR) treatment, a condition where a stented vessel is obstructed by plaque or scar tissue. It possesses a paclitaxel coating, which provides a therapeuticdosage to the vessel wall, thereby diminishing ISR recurrence without the need for extra stents or radiation. Trials in a clinical setting have demonstrated a 49% reduction in heart attack risk at the targeted site, with minimal reported adverse incidents.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Drug Eluting Balloons Catheters Market?
North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13429
This Report Delivers Insight On:
1. How big is the drug eluting balloons catheters market, and how is it changing globally?
2. Who are the major companies in the drug eluting balloons catheters market, and how are they performing?
3. What are the key opportunities and risks in the drug eluting balloons catheters market right now?
4. Which products or customer segments are growing the most in the drug eluting balloons catheters market?
5. What factors are helping or slowing down the growth of the drug eluting balloons catheters market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model